Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis

Amid all the panic over how GLP-1 medicines portend upheaval in biotech, pharma, and the entirety of global capitalism, an impending clinical readout could have legitimate implications for the treatment of a common disease.